Clinical Trials in Libourne, France
Locations / Libourne, France
Delta Trials hosts 183 clinical trials conducted in Libourne, France, making it a notable site of clinical research activity. These trials covering 185 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 13 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Libourne.
183
Total Trials
185
Conditions
13
Terminated since 2020
Browse by condition (185 total)
- Colorectal cancer 14 trialsAll Colorectal cancer trials
- Non-small cell lung cancer 6 trialsAll Non-small cell lung cancer trials
- Pancreatic cancer 5 trialsAll Pancreatic cancer trials
- Rheumatoid arthritis 5 trialsAll Rheumatoid arthritis trials
- Asthma 5 trialsAll Asthma trials
- Breast cancer 5 trialsAll Breast cancer trials
- Multiple myeloma 4 trialsAll Multiple myeloma trials
- Multiple sclerosis 4 trialsAll Multiple sclerosis trials
- Lymphoma 4 trialsAll Lymphoma trials
- Essential thrombocythemia 3 trialsAll Essential thrombocythemia trials
- Chronic myeloid leukemia 3 trialsAll Chronic myeloid leukemia trials
- Atrial fibrillation 3 trialsAll Atrial fibrillation trials
- Lung cancer 3 trialsAll Lung cancer trials
- Carcinoma, non-small-cell lung 3 trialsAll Carcinoma, non-small-cell lung trials
- All Chronic obstructive pulmonary disease (COPD) trials
- HIV infections 3 trialsAll HIV infections trials
- All Non-squamous non-small cell lung cancer trials
- Prostate cancer 3 trialsAll Prostate cancer trials
- COVID-19 2 trialsAll COVID-19 trials
- Follicular lymphoma (fl) 2 trialsAll Follicular lymphoma (fl) trials